baber/WOPTO huggingface dataset:
Patent NZ-332242-A (NZ)
Title: Inhaler including a suction tube, for insertion into a blister pack, and a support unit for the suction tube and blister pack
Inventor: VON SCHUCKMANN ALFRED
IPC: A61J1/03
Filed: 1997-04-25
Abstract: An inhaler, for administering dry powder, comprises a suction tube S having an inlet 19 at one end and an outlet 17 at the other end.  The suction tube includes at the one end an inlet section configured for insertion into a blister pack B having a plurality of blisters each containing a dose of powder containing a medicament.  An inhalation channel 31 provides fluid communication between the inlet and outlet.  A support unit V supports, in use, blister pack B.  The support unit includes a guide wall 6 adjacent which, in use, the planar surface of the blister pack is disposed.  The guide wall includes a plurality of apertures 15 acting as guide portions in alignment with respective blisters of the blister pack, each aperture guiding the inlet section of the suction tube into a respective blister and supporting the suction tube when so guided.
Patent NZ-334695-A (NZ)
Title: Halftone image patterning with skew minimum mesh and elongated darkening tone
Inventor: ASHWORTH WILLIAM FREDERICK
IPC: G03F5/22
Filed: 1999-03-16
Abstract: [ Patent 334695 This screen system which is used to produce a colored halftone image comprises a plurality of screens where: a)	each screen represents different colors or black in the image; b)	each screen has a pattern of printing areas defining a minimum mesh; c)	each pattern has a parcel of printing areas which repeats throughout the screen; and d)	two or more of the screens have different non-orthogonal minimum meshes and have printing areas which extend to join first along directions other than that of their closest spacing. Also included is a pattern for a half tone image where the printing areas define a non-orthogonal minimum mesh and extend first with darkening tone along directions other than those of closest spacing.
Patent NZ-334779-A (NZ)
Title: Building panel with inner insulating portion and outer portion engages together, with integral securing portion of lower density
Inventor: NAKHLE ELIAS
IPC: E04B1/62
Filed: 1999-03-19
Abstract: Building panel 2 is formed of an inner portion 6 having relatively high heat insulation characteristics (typically of foamed plastic sheet), and an outer portion of settable material 5 (typically concrete) engaged with inner portion 6 (typically via dovetails 8). Panel 2 has integral securing portion 12 of lower density than the settable material. (Typically the portion 12 facilitates moulding and lifting of panel 2). Details of moulding by the settable material being formed over the inner portion 6 are also disclosed. Typically grooves 10 are provided at an inner surface  of portion 6 for reticulation of services.
Patent NZ-335534-A (NZ)
Title: Method of identifying potential pharmaceuticals from plant extracts
Inventor: BEAUFOUR ALBERT
IPC: C12Q1/68
Filed: 1997-11-05
Abstract: The method of identifying pharmaceuticals from plant extracts comprises: a) administering a plant extract containing at least one potential pharmaceutical to a cell type; b) isolating a protein or RNA from the plant extract treated cell type; c) identifying which of the protein or RNA isolated in step b) is not present in the same concentration in the untreated cell type; d) administering at least one potential pharmaceutical found in the plant extract of step a) to the untreated cell type; e) isolating the protein or RNA from the pharmaceutical treated cell type and f) identifying which of the potential pharmaceuticals administered in step d) also result in the expression or suspension of the protein or RNA which is not present in the same concentration in the untreated type.
Patent NZ-504944-A (NZ)
Title: A stable liquid composition of an amine such as pseudoephedrine and an a NSAID drug such as ibuprofen which provides enhanced absorption of the amine into the blood
Inventor: GELOTTE CATHY KLECH
IPC: A61K31/192
Filed: 2000-06-06
Abstract: A stable liquid composition contains a pharmaceutically acceptable amine and a non-steroidal anti-inflammatory drug with the composition providing an enhanced absorption rate of the amine into the blood of a human compared with a corresponding composition containing only the amine and not the non-steroidal anti-inflammatory drug.
Patent NZ-506196-A (NZ)
Title: An isolated staphylococcal abc transporter protein for use in treatment and diagnosis of staphylococcal infections
Inventor: BURNIE JAMES PETER
IPC: A61K48/00
Filed: 1999-03-25
Abstract: An isolated Staphylococcal ABC transporter protein or a partially modified form of the protein having at least 70% homology therewith, or an immunogenic fragment of the protein for use in a method of treatment or diagnosis of the human or animal body. Also described is a diagnostic test method for Staphylococci, comprising the steps of: (i) reacting a Staphylococcal ABC transporter protein, or an immunogenic fragment of the protein with a sample; ii) detecting an antibody-antigen binding reaction; and iii) correlating detection of the reaction with the presence of Staphylococci.
Patent NZ-507573-A (NZ)
Title: Thienylazolylalkoxyethanamine derivatives, pharmaceutical compositions thereof, and their use as analgesics
Inventor: MERCE-VIDAL RAMON
IPC: C07D409/06
Filed: 1999-04-15
Abstract: A thienylazolylalkoxyethanamine derivative of formula (I), wherein: R1 is H, halogen or alkyl; R2, R3 and R4 are independently H or alkyl Az is a radical of formula (III) that contains from one to three nitrogen atoms; Z1, Z2 and Z3 are independently N or CH; or physiologically acceptable salts thereof. Also described are pharmaceutical compositions that comprise the compound of formula (I) and a pharmaceutically acceptable excipient. The compounds of formula (I) are useful as analgesics.
Patent NZ-507760-A (NZ)
Title: Amide derivatives and nociceptin antagonists
Inventor: SHINKAI HISASHI
IPC: C07D221/16
Filed: 1999-03-23
Abstract: A nociceptin antagonist containing an amide derivative of the formula [I] or its salts, where: R1 and R2 are hydrogen, alkyl optionally substituted by hydroxy, amino, alkylamino or di-alkylamino; R3 and R4 are hydrogen, halogen or alkyl; ring A is aryl or heterocyclic group where the aryl is an aromatic hydrocarbon and the heterocyclic group has O, N or S as hetero atoms; ring B is phenyl, thienyl, furyl, pyrrolyl, pyrrolidinyl, oxazolyl or cyclohexenyl; and X is hydrogen, halogen, alkyl optionally substituted by alkoxy, alkenyl, amino, cyano or a group of the formula [II], where: E is a single bond, carbonyl, sulphinyl, -O-, -S-, -NHCO-, -CH=CR6- or -NR7-, where: R6 is hydrogen or aryl: R7 is hydrogen, alkyl or alkoxycarbonyl; ring G is aryl, heterocyclic group, cycloalkyl or condensed aryl; R5 is halogen, hydroxy, alkyl optionally substituted by halogen, hydroxy, alkanoyloxy and alkoxy optionally substituted by alkoxy, alkoxy optionally substituted by alkoxy, amino, alkylamino, di-alkylamino, nitro, cyano, alkanoyl, alkanoyloxy, carboxy, alkoxycarbonyl, alkylsulfonyl or phenyl; t is 0 to 5, which indicates the number of substituents on the ring G, when t is 2 to 5, each R5 may be the same or different; m is 0 to 8; and n is 0 to 4.
Patent NZ-510551-A (NZ)
Title: Substituted 3-cyanoquinolines useful as protein tyrosine kinases inhibitors
Inventor: ZHANG NAN
IPC: A61K31/496
Filed: 1999-09-22
Abstract: A  3-cyanoquinoline derivative or  a  pharmaceutically acceptable salt thereof has the formula 1 wherein: X  is  an  optionally substituted bicyclic aryl or  bicyclic heteroaryl  ring system of 8 to 12 atoms where the  bicyclic heteroaryl  ring contains 1 to 4 heteroatoms  selected  from N,  O,  and  S with the proviso that the bicyclic heteroaryl ring does not contain O-O, S-S, or S-O bonds or X is -A-T-L- ; A  is  optionally  substituted  pyridinyl,  pyrimidinyl,  or phenyl ring; T is bonded to a carbon of A and is -NH(CH2)m-, -O(CH2)m-, - S(CH2)m-, -NR(CH2)m-, -(CH2)m-,  -(CH2)m-NH-, -(CH2)m-O-,  - (CH2)m-S- or -(CH2)m-NR-; L  is an optionally substituted phenyl ring  provided that L can  be an unsubstituted phenyl ring only when m>0 and T  is not  -CH2NH- or -CH2O- or L is an optionally substituted  5- or  6-membered  heteroaryl ring where  the  heteroaryl  ring contains 1 to 3 heteroatoms selected from N, O, and S,  with the  proviso that the heteroaryl ring does not contain  O-O, S-S, or S-O bonds; Z is -NH-, -O-, -S-, or -NR-; R is alkyl or carboalkyl; G1,  G2,  R1  and  R4 are independently, hydrogen,  halogen, alkyl,    alkenyl,    alkynyl,    alkenyloxy,    alkynyloxy, hydroxymethyl,    halomethyl,   alkanoyloxy,    alkenoyloxy, alkynoyloxy,      alkanoyloxymethyl,      alkenoyloxymethyl, alkynoyloxymethyl,    alkoxymethyl,    alkoxy,    alkylthio, alkylsulphinyl,      alkylsulphonyl,      alkylsulphonamido, alkenylsulphonamido,      alkynylsulphonamido,      hydroxy, trifluoromethyl,  trifluoromethoxy, cyano,  nitro,  carboxy, carboalkoxy    carboalkyl,  phenoxy,  phenyl,   thiophenoxy, benzyl,   amino,   hydroxyamino,  alkoxyamino,   alkylamino, dialkylamino,  N-alkylcarbamoyl,  N,N-dialkylcarbamoyl,   N- alkyl-N-alkenylamino,    N,N-dialkenylamino,    phenylamino, benzylamino,  a group of formula (2), R8R9-CH-M-(C(R6)2)k-Y- ,   R7-(C(R6)2)g-Y-,  R7-(C(R6)2)p-M-(C(R6)2)k-Y-  or   Het- (C(R6)2)q-W-(C(R6)2)k-Y- or R1 and R4 are as  defined  above and  G1  or  G2  or  both  are  R2-NH-  or  if  any  of  the substituents  R1,  G1, G2, or R4 are located  on  contiguous carbon  atoms  then  they  may  be  taken  together  as  the divalent radical -O-(C(R6)2)-O-; Y  is  a divalent radical selected from the group consisting of -C(H2)a-, -O- or -NR6-; R2,  R3, R6, R7, R8, R9, M, W and Het are as defined in  the specification; a  and n are independently 0 or 1; g and s are independently 1-6;  k, u, v and q are independently  is 0-4; m is  0-3;  p is  2-4;  r is 1-4 wherein the sum of u+v is 2-4 limited  by the provisos listed in the specification. The  compounds are useful for inhibiting the  growth  of  or eradicating neoplasms or polycystic kidney disease.
Patent NZ-515644-A (NZ)
Title: Oil-core compositions for the sustained release of hydrophobic drugs
Inventor: MANTRIPRAGADA SANKARAM B
IPC: A61K31/445
Filed: 2000-06-02
Abstract: Physiologically active oil-core particles, wherein each particle comprises: a hydrophobic oil core comprising at least one triglyceride, and a hydrophobic drug; and at least one amphipathic surfactant. Also disclosed are methods of making such an oil-core particle.
Patent NZ-517182-A (NZ)
Title: Antistatic agent
Inventor: DOBLER MARTIN
IPC: C08K5/42
Filed: 2000-08-03
Abstract: Use of perfluoroalkylsulfonic acid salts of the formula (I) RA-SO3 X (I) in which: R means perfluorintaed linear or branched carbon chains having 1 to 30 carbon atoms, A means a direct bond or a divalent aromatic nucleus, X means an alkylated and/or arylated ammonium ion NR'R''R'''R'''', phosphonium ion PR'R''R'''R'''', sulfonium ion S R'R''R''', and a substituted or unsubstituted imidazolinium ion, pyridinium ion or tropylium ion, in which R', R'', R''', R'''' mutually independently denote halogenated or non-halogenated, linear or branched carbon chains having 1 to 30 carbon atoms or aromatic residues or alkylaromatic residues having 1 to 4 carbon atoms in the alkyl portion, as an antistatic additive in polycarbonates.
Patent NZ-519976-A (NZ)
Title: Substituted 1 and 2 naphthol mannich bases
Inventor: GERLACH MATTHIAS
IPC: C07C225/16
Filed: 2000-12-20
Abstract: A substituted 1- or 2-naphthol Mannich base of the general formula I. Compounds of formula I may be used in a medicament for treating conditions such as pain, inflammatory reactions, allergic reactions, drug and or alcohol abuse, diarrhoea, gastritis, ulcers, cardiovascular diseases, urinary incontinence, depression, migraines, shocknarcolepsy, asthma and hyperkinetic syndrome. A process for the production of the abovementioned compounds is also disclosed.
Patent NZ-520656-A (NZ)
Title: Heterocyclic side chain containing metalloprotease inhibitors
Inventor: PIKUL STANISLAW
IPC: A61P31/00
Filed: 2001-03-20
Abstract: Disclosed are compounds which are inhibitors of metalloproteases and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the compounds have a structure according to formulae shown; R1, R2, n, A, E, X, G and Z have the meanings described in the specification. Pharmaceutical compositions comprising these compounds are also described, and methods of inhibiting metalloprotease-related diseases such as cancer.
Patent NZ-521605-A (NZ)
Title: Method of shore protection with reef oriented to refract incoming waves in predetermined direction
Inventor: BLACK KERRY PETER
IPC: E02B3/06
Filed: 2001-08-29
Abstract: A method of shore protection is provided which includes determining a required direction of travel of incoming waves to a shore or shore portion to protect the shore and locating at least one elongate reef (1) on the sea bed (2). The reef (1) is oriented at a pre-selected angle relative to an average or mode direction of travel of incoming waves (W) and having pre-selected dimensions selected to modify the direction of travel of incoming waves to the required direction after passing over the reef (1).
Patent NZ-522139-A (NZ)
Title: In situ recovery from a hydrocarbon containing formation
Inventor: BERCHENKO ILYA EMIL
IPC: E21B36/00
Filed: 2001-04-24
Abstract: A hydrocarbon containing formation may be treated using an in situ thermal process. Heat may be applied to the formation to raise a temperature of a portion of the formation to a pyrolysis temperature. Heat input into the formation may be controlled to raise the temperature of portion at a selected rate during pyrolysis of hydrocarbons within the formation. A mixture of hydrocarbons, H2, and/or other formation fluids may be produced from the formation. The mixture may be separated into condensable hydrocarbons and non-condensable hydrocarbons. The condensable hydrocarbons removed from the formation may be a high quality oil that has a relatively low olefin content and a relatively high API gravity.
Patent NZ-528120-A (NZ)
Title: N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
Inventor: NAGANAWA ATSUSHI
IPC: A61K31/34
Filed: 2002-03-11
Abstract: Disclosed are N-phenylarylsulfonylamide compounds of formula, (I), wherein: R1 is COOH, 5-tetrazolyl, 5-oxo-1,2,4-oxadiazolyl, CH2OH or 5-oxo-1,2,4-thiadiazolyl, R2 is H, methyl, methoxy or chloro, R3 and R4 are a combination of (1) methyl and methyl, (2) methyl and chloro, (3) chloro and methyl, or (4) trifluoromethyl and hydrogen, or R3 and R4 are taken together with the carbon to which R3 and R4 are attached to form (5) cyclopentane, (6) cyclohexene or (7) benzene ring, R5 is isopropyl, isobutyl, 2-methyl-2-propenyl, cyclopropylmethyl, methyl, ethyl, propyl, 2-propenyl or 2-hydroxy-2-methylpropyl, Ar is thiazolyl optionally substituted with methyl, pyridyl or 5-methyl-2-furyl, and n is zero or 1, and where R1 is 5-tetrazolyl, 5-oxo-1,2,4-oxadiazolyl or 5-oxo-1,2,4-thiadiazolyl, n is zero. The compounds are used for the manufacture of medicaments for the treatment of pain, pyrexia, pollakiuria, acraturesis, lower urinary tract disease syndrome and cancer.
Patent NZ-531745-A (NZ)
Title: A method and system for processing image data
Inventor: DEVANE PETER
Filed: 2004-03-12
Abstract: A method for processing x-ray images to determine the rate of wear in prosthesis is described. A 3D model of the prosthesis of a patient is made and compared with a model made of the same prosthesis at an earlier stage in time. The 3D models are created by taking anterior-posterior and lateral x-rays of the patient and finding the exact locations of the centre of the cup and head of the prosthesis. Various techniques are described for finding the centers of the cup and head.
Patent NZ-532114-A (NZ)
Title: Method for buying and selling real estate
Inventor: ARNALL LEIGH RAYMOND
IPC: G06F15/16
Filed: 2004-04-05
Abstract: An internet-based system for exchanging the ownership of a property between a first party desirous of selling the property and at least one second party desirous of buying the property in return for valuable consideration comprises an internet site, and software operable to control the operation of the site and to facilitate communication between a the first party, at second party, and an agent acting for all parties. The internet site and the software together allows the first party to access the internet to provide consent to the agent to act on their behalf in selling the property, and also to provide informed consent for the agent to act on behalf of the second party in buying the property, neither the first party nor the agent indicating an expectation of the valuable consideration; the agent to make known to the second party that the property is for sale by placing a notice on the internet site, neither the second party nor the agent indicating an expectation of the valuable consideration; the second party to access the internet site to provide consent to the agent to act on their behalf in buying the property, and also to provide informed consent for the agent to act on behalf of the first party in selling the property; the second party to access the internet site to make a secret bid for the property during a predetermined period of time and the first party to access the internet site to inspect the secret bid or bids at the conclusion of the predetermined period of time, and the first party to accept or refuse the bid or bids by indicating this on the internet site to the agent and the second party. A bid includes a transaction fee nominated by the agent and to be paid to the agent by the second party if the bid is successful, and the valuable consideration the second party is prepared to pay to the first party to purchase the property.
Patent NZ-539977-A (NZ)
Title: Hammermill constructed to alleviate problems with material clogging or passing through screen before being thoroughly sized
Inventor: ELLIOT JAMES C
IPC: B02C13/04
Filed: 2003-10-22
Abstract: A hammermill is disclosed having a housing, a rotor assembly, a plurality of hammers, and a attrition plate assembly is provided to reduce oversized particulate material to a desired size. The housing has a sidewall that extends between an inlet end and an discharge end which defines an enclosed work space. The rotor assembly is disposed within the housing for rotation about a longitudinal axis of the housing. The plurality of hammers is coupled to the rotor assembly and is disposed within the enclosed work space. The attrition plate assembly has a generally circular configuration and is removably secured to the sidewall within the enclosed work space of the housing. The attrition plate assembly is arranged such that a portion of at least one hammer of the plurality of hammers is spaced from and overlies a portion of the first attrition plate assembly so that the at least one hammer and the attrition plate assembly cooperate to reduce particulate material to a desired size and to urge the particulate material toward the discharge end of the housing.
Patent NZ-542125-A (NZ)
Title: A bed monitoring system
Inventor: BAUTOVICH BASIL C
IPC: A61G7/05
Filed: 2004-02-06
Abstract: Apparatus and methods for monitoring movement of a subject in a bed, with particular application to beds in nursing homes catering for frail or mentally ill patients, are disclosed. A generator (9, 11) establishes a field, for example a form of electromagnetic radiation, having a periphery (12, 13, 14) above the surface of the bed. A sensor (6, 8) detects when the subject crosses the periphery and enters the field and generates a movement signal that may trigger an alert.
Patent NZ-547306-A (NZ)
Title: System and method of pulverizing and extracting moisture
Inventor: GRAHAM WILLIAM
IPC: B02C23/08
Filed: 2004-10-18
Abstract: A venturi (18) receives incoming material through an inlet tube (12) and subjects the material to pulverization. The material, as it undergoes pulverization, is further subject to moisture extraction and drying. An airflow generator (32), coupled to the venturi, generates a high speed airflow to pull the material through the venturi and into an inlet aperture in the airflow generator. The airflow generator directs the received pulverized material to an outlet where the material may be subsequently separated from the air.
Patent NZ-560231-A (NZ)
Title: Rapid tooling system and methods for manufacturing abrasive articles
Inventor: NEVORET DAMIEN
IPC: B24D11/00
Filed: 2006-02-21
Abstract: A rapid structuring media cartridge includes a cartridge body, a first binder and first abrasive particles. The cartridge is operable to deposit successive patterned layers including the first binder and first abrasive particles to form an abrasive structure.
Patent NZ-567095-A (NZ)
Title: Anti-infective agent and use thereof
Inventor: GELDER FRANK B
IPC: A61K38/05
Filed: 2009-04-01
Abstract: Provided is the use of a muramyl dipeptide (MDP)/DNA-microparticle for the manufacture of a medicament for the prophylactic or therapeutic treatment of an infection caused by a virus and/or a bacterium in a subject in need thereof. The medicament can induce a Th1-type immune response and the infection to be treated can be influenza, plague or tuberculosis.
Patent NZ-569563-A (NZ)
Title: Methods for treating cutaneous lupus using aminoisoindoline compounds
Inventor: ZELDIS JEROME B
IPC: A61P17/00
Filed: 2006-12-28
Abstract: Disclosed herein are the use of aminoisoindoline compounds of (+)-2-[I-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-I,3-dione, or a pharmaceutically acceptable salt or solvate thereof: substantially free of its (-) enantiomer; 4-(amino)-2-(2,6- dioxo(3-piperidyl))-isoindoline-I,3-dione, or a pharmaceutically acceptable salt, solvate or stereoisomer thereof; 3-(4-amino-I-oxo- 1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione, or a pharmaceutically acceptable salt, solvate or stereoisomer thereof; cyclopropyl { 2-[(1 S)-l-(3 -ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl] -3-oxoisoindolin-4-yl} carboxamide in the manufacture of a composition for treating cutaneous lupus.
Patent NZ-579339-A (NZ)
Title: Atorvastatin strontium salt and pharmaceutical composition comprising the same
Inventor: KIM EUN SOOK
IPC: A61K31/40
Filed: 2008-01-21
Abstract: Disclosed is an atorvastatin strontium salt of formula (I) or its hydrates of polymorphs thereof. Further disclosed are methods of preparing said atorvastatin strontium salt and pharmaceutical compositions thereof.
Patent NZ-579721-A (NZ)
Title: 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition
Inventor: MOORE NICHOLAS
IPC: A61P25/04
Filed: 2008-03-14
Abstract: Disclosed is the use of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine (the pictured compound) for the treatment of pain. The compound has combined serotonin reuptake, 5-HT3 and 5-HT1A activity. The specification also discloses the use of the compound to treat residual symptoms in depression.
Patent NZ-581790-A (NZ)
Title: A method of selecting media flow
Inventor: SYNNERGREN PER
IPC: H04L29/06
Filed: 2008-06-10
Abstract: A method of selecting media flow in a cellular radio system and a node in a cellular radio system are disclosed. The node comprises means for accessing a policy control function (PCRF); means for receiving a request for a service or a media flow from a user of the cellular radio system, and means for deciding that an already existing Packet Data Protocol (PDP), context or EPS Bearer is to be used for the requested service or media flow based on information received from the PCRF in case network requested PDP context activation is configured to be used. Further disclosed is a mobile station comprising a self-configuring unit adapted to self-configure the mobile terminal by using received PDP context or EPS Bearer information for finding out that it already has this PDP context or EPS Bearer activated.